Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 7,751 | 6,012 | 5,473 | 7,258 | 5,096 |
| Cost of Goods | 4,920 | 4,428 | 4,242 | 4,962 | 3,838 |
| Gross Profit | 2,832 | 1,584 | 1,231 | 2,295 | 1,258 |
| Operating Expenses | 3,130 | 2,587 | 2,860 | 3,558 | 3,100 |
| Operating Income | 621 | -575 | -1,387 | -300 | -1,004 |
| Other Income | -101 | -126 | -144 | -136 | -135 |
| Pre-tax Income | 521 | -700 | -1,530 | -437 | -1,139 |
| Income Tax | 6 | 1 | 1 | 1 | 1 |
| Net Income Continuous | 515 | -702 | -1,532 | -438 | -1,140 |
| Net Income | $515 | $-702 | $-1,532 | $-438 | $-1,140 |
| EPS Basic Total Ops | 0.09 | -0.09 | -0.20 | -0.06 | -0.15 |
| EPS Basic Continuous Ops | 0.07 | -0.09 | -0.20 | -0.06 | -0.15 |
| EPS Diluted Total Ops | 0.09 | -0.09 | -0.20 | -0.06 | -0.15 |
| EPS Diluted Continuous Ops | 0.07 | -0.09 | -0.20 | -0.06 | -0.15 |
| EPS Diluted Before Non-Recurring Items | 0.06 | -0.09 | -0.20 | -0.06 | N/A |
| EBITDA(a) | $1,306 | $111 | $-705 | $377 | $-319 |